nodes	percent_of_prediction	percent_of_DWPC	metapath
Propiomazine—DRD4—Gilles de la Tourette syndrome	0.402	0.486	CbGaD
Propiomazine—DRD2—Gilles de la Tourette syndrome	0.24	0.29	CbGaD
Propiomazine—HTR2A—Gilles de la Tourette syndrome	0.185	0.224	CbGaD
Propiomazine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00326	0.0822	CbGeAlD
Propiomazine—DRD4—brain—Gilles de la Tourette syndrome	0.00161	0.0405	CbGeAlD
Propiomazine—CHRM4—nervous system—Gilles de la Tourette syndrome	0.00159	0.0401	CbGeAlD
Propiomazine—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.00153	0.0386	CbGeAlD
Propiomazine—DRD1—midbrain—Gilles de la Tourette syndrome	0.00129	0.0325	CbGeAlD
Propiomazine—CHRM5—nervous system—Gilles de la Tourette syndrome	0.00124	0.0313	CbGeAlD
Propiomazine—CHRM4—brain—Gilles de la Tourette syndrome	0.00121	0.0306	CbGeAlD
Propiomazine—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.00119	0.0302	CbGeAlD
Propiomazine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00113	0.0286	CbGeAlD
Propiomazine—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.00111	0.028	CbGeAlD
Propiomazine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00109	0.0276	CbGeAlD
Propiomazine—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00107	0.027	CbGeAlD
Propiomazine—DRD1—nervous system—Gilles de la Tourette syndrome	0.00106	0.0267	CbGeAlD
Propiomazine—DRD1—central nervous system—Gilles de la Tourette syndrome	0.00102	0.0257	CbGeAlD
Propiomazine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000999	0.0252	CbGeAlD
Propiomazine—CHRM5—brain—Gilles de la Tourette syndrome	0.000949	0.024	CbGeAlD
Propiomazine—ADRA1B—brain—Gilles de la Tourette syndrome	0.000867	0.0219	CbGeAlD
Propiomazine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000852	0.0215	CbGeAlD
Propiomazine—ADRA1D—brain—Gilles de la Tourette syndrome	0.000848	0.0214	CbGeAlD
Propiomazine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000821	0.0207	CbGeAlD
Propiomazine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.00082	0.0207	CbGeAlD
Propiomazine—DRD1—brain—Gilles de la Tourette syndrome	0.000808	0.0204	CbGeAlD
Propiomazine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000791	0.02	CbGeAlD
Propiomazine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.000775	0.0196	CbGeAlD
Propiomazine—DRD2—midbrain—Gilles de la Tourette syndrome	0.00076	0.0192	CbGeAlD
Propiomazine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000747	0.0189	CbGeAlD
Propiomazine—CHRM3—nervous system—Gilles de la Tourette syndrome	0.000694	0.0175	CbGeAlD
Propiomazine—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.000668	0.0169	CbGeAlD
Propiomazine—CHRM2—brain—Gilles de la Tourette syndrome	0.000651	0.0164	CbGeAlD
Propiomazine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000637	0.0161	CbGeAlD
Propiomazine—HTR2C—brain—Gilles de la Tourette syndrome	0.000628	0.0158	CbGeAlD
Propiomazine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000625	0.0158	CbGeAlD
Propiomazine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000613	0.0155	CbGeAlD
Propiomazine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000601	0.0152	CbGeAlD
Propiomazine—CHRM1—brain—Gilles de la Tourette syndrome	0.000593	0.015	CbGeAlD
Propiomazine—CHRM3—brain—Gilles de la Tourette syndrome	0.00053	0.0134	CbGeAlD
Propiomazine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000501	0.0127	CbGeAlD
Propiomazine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000493	0.0125	CbGeAlD
Propiomazine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000487	0.0123	CbGeAlD
Propiomazine—DRD2—brain—Gilles de la Tourette syndrome	0.000477	0.0121	CbGeAlD
Propiomazine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000475	0.012	CbGeAlD
Propiomazine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000412	0.0104	CbGeAlD
Propiomazine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000397	0.01	CbGeAlD
Propiomazine—HRH1—brain—Gilles de la Tourette syndrome	0.000377	0.00952	CbGeAlD
Propiomazine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.000341	0.0478	CrCbGaD
Propiomazine—HTR2A—brain—Gilles de la Tourette syndrome	0.000315	0.00795	CbGeAlD
Propiomazine—Mesoridazine—DRD3—Gilles de la Tourette syndrome	0.000265	0.0372	CrCbGaD
Propiomazine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.000257	0.036	CrCbGaD
Propiomazine—Cyamemazine—HTR2A—Gilles de la Tourette syndrome	0.000233	0.0326	CrCbGaD
Propiomazine—Fluphenazine—DRD3—Gilles de la Tourette syndrome	0.000232	0.0326	CrCbGaD
Propiomazine—Methotrimeprazine—DRD4—Gilles de la Tourette syndrome	0.000222	0.0311	CrCbGaD
Propiomazine—Chlorprothixene—DRD3—Gilles de la Tourette syndrome	0.000212	0.0296	CrCbGaD
Propiomazine—Triflupromazine—DRD2—Gilles de la Tourette syndrome	0.000209	0.0293	CrCbGaD
Propiomazine—Acepromazine—DRD2—Gilles de la Tourette syndrome	0.000193	0.0271	CrCbGaD
Propiomazine—Promazine—DRD4—Gilles de la Tourette syndrome	0.000192	0.0269	CrCbGaD
Propiomazine—Methotrimeprazine—DRD3—Gilles de la Tourette syndrome	0.000191	0.0268	CrCbGaD
Propiomazine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.000189	0.0265	CrCbGaD
Propiomazine—Thiothixene—DRD2—Gilles de la Tourette syndrome	0.000186	0.0261	CrCbGaD
Propiomazine—Pipotiazine—DRD2—Gilles de la Tourette syndrome	0.000186	0.0261	CrCbGaD
Propiomazine—Mesoridazine—DRD2—Gilles de la Tourette syndrome	0.000184	0.0257	CrCbGaD
Propiomazine—Trimipramine—SLC6A3—Gilles de la Tourette syndrome	0.000182	0.0255	CrCbGaD
Propiomazine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.000178	0.0249	CrCbGaD
Propiomazine—Chlorpromazine—DRD4—Gilles de la Tourette syndrome	0.000169	0.0237	CrCbGaD
Propiomazine—Fluphenazine—DRD2—Gilles de la Tourette syndrome	0.000161	0.0225	CrCbGaD
Propiomazine—Acepromazine—HTR2A—Gilles de la Tourette syndrome	0.000149	0.0209	CrCbGaD
Propiomazine—Chlorprothixene—DRD2—Gilles de la Tourette syndrome	0.000146	0.0205	CrCbGaD
Propiomazine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.000146	0.0205	CrCbGaD
Propiomazine—Chlorpromazine—DRD3—Gilles de la Tourette syndrome	0.000146	0.0204	CrCbGaD
Propiomazine—Thiothixene—HTR2A—Gilles de la Tourette syndrome	0.000144	0.0201	CrCbGaD
Propiomazine—Pipotiazine—HTR2A—Gilles de la Tourette syndrome	0.000144	0.0201	CrCbGaD
Propiomazine—Mesoridazine—HTR2A—Gilles de la Tourette syndrome	0.000142	0.0199	CrCbGaD
Propiomazine—Thioridazine—DRD2—Gilles de la Tourette syndrome	0.000138	0.0194	CrCbGaD
Propiomazine—Trimipramine—DRD2—Gilles de la Tourette syndrome	0.000135	0.019	CrCbGaD
Propiomazine—Methotrimeprazine—DRD2—Gilles de la Tourette syndrome	0.000132	0.0185	CrCbGaD
Propiomazine—Promethazine—DRD2—Gilles de la Tourette syndrome	0.00013	0.0183	CrCbGaD
Propiomazine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.000129	0.018	CrCbGaD
Propiomazine—Perphenazine—DRD2—Gilles de la Tourette syndrome	0.000127	0.0178	CrCbGaD
Propiomazine—Fluphenazine—HTR2A—Gilles de la Tourette syndrome	0.000124	0.0174	CrCbGaD
Propiomazine—Promazine—DRD2—Gilles de la Tourette syndrome	0.000115	0.0161	CrCbGaD
Propiomazine—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.000114	0.0159	CrCbGaD
Propiomazine—Chlorprothixene—HTR2A—Gilles de la Tourette syndrome	0.000113	0.0159	CrCbGaD
Propiomazine—Thioridazine—HTR2A—Gilles de la Tourette syndrome	0.000107	0.015	CrCbGaD
Propiomazine—Trimipramine—HTR2A—Gilles de la Tourette syndrome	0.000105	0.0146	CrCbGaD
Propiomazine—Methotrimeprazine—HTR2A—Gilles de la Tourette syndrome	0.000102	0.0143	CrCbGaD
Propiomazine—Chlorpromazine—DRD2—Gilles de la Tourette syndrome	0.000101	0.0141	CrCbGaD
Propiomazine—Promethazine—HTR2A—Gilles de la Tourette syndrome	0.000101	0.0141	CrCbGaD
Propiomazine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	9.93e-05	0.0139	CrCbGaD
Propiomazine—Perphenazine—HTR2A—Gilles de la Tourette syndrome	9.82e-05	0.0138	CrCbGaD
Propiomazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	9.24e-05	0.000734	CbGpPWpGaD
Propiomazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	9.22e-05	0.000733	CbGpPWpGaD
Propiomazine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.19e-05	0.00073	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.19e-05	0.00073	CbGpPWpGaD
Propiomazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	9.19e-05	0.00073	CbGpPWpGaD
Propiomazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	9.17e-05	0.000728	CbGpPWpGaD
Propiomazine—CHRM5—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.11e-05	0.000723	CbGpPWpGaD
Propiomazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	9.09e-05	0.000722	CbGpPWpGaD
Propiomazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	9.07e-05	0.00072	CbGpPWpGaD
Propiomazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	9.04e-05	0.000718	CbGpPWpGaD
Propiomazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	9.01e-05	0.000716	CbGpPWpGaD
Propiomazine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	8.94e-05	0.00071	CbGpPWpGaD
Propiomazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	8.93e-05	0.000709	CbGpPWpGaD
Propiomazine—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	8.91e-05	0.000707	CbGpPWpGaD
Propiomazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	8.9e-05	0.000707	CbGpPWpGaD
Propiomazine—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	8.88e-05	0.000705	CbGpPWpGaD
Propiomazine—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.87e-05	0.000704	CbGpPWpGaD
Propiomazine—Promazine—HTR2A—Gilles de la Tourette syndrome	8.85e-05	0.0124	CrCbGaD
Propiomazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	8.83e-05	0.000701	CbGpPWpGaD
Propiomazine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	8.77e-05	0.000696	CbGpPWpGaD
Propiomazine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.75e-05	0.000695	CbGpPWpGaD
Propiomazine—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.68e-05	0.000689	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.56e-05	0.00068	CbGpPWpGaD
Propiomazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	8.47e-05	0.000673	CbGpPWpGaD
Propiomazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	8.45e-05	0.000671	CbGpPWpGaD
Propiomazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	8.42e-05	0.000669	CbGpPWpGaD
Propiomazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	8.4e-05	0.000667	CbGpPWpGaD
Propiomazine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.38e-05	0.000665	CbGpPWpGaD
Propiomazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	8.31e-05	0.00066	CbGpPWpGaD
Propiomazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	8.29e-05	0.000659	CbGpPWpGaD
Propiomazine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.21e-05	0.000652	CbGpPWpGaD
Propiomazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	7.99e-05	0.000635	CbGpPWpGaD
Propiomazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.98e-05	0.000634	CbGpPWpGaD
Propiomazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.97e-05	0.000633	CbGpPWpGaD
Propiomazine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.97e-05	0.000633	CbGpPWpGaD
Propiomazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	7.97e-05	0.000633	CbGpPWpGaD
Propiomazine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	7.94e-05	0.000631	CbGpPWpGaD
Propiomazine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.88e-05	0.000626	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.86e-05	0.000624	CbGpPWpGaD
Propiomazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	7.84e-05	0.000623	CbGpPWpGaD
Propiomazine—Chlorpromazine—HTR2A—Gilles de la Tourette syndrome	7.79e-05	0.0109	CrCbGaD
Propiomazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.63e-05	0.000606	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.63e-05	0.000606	CbGpPWpGaD
Propiomazine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.43e-05	0.00059	CbGpPWpGaD
Propiomazine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.25e-05	0.000576	CbGpPWpGaD
Propiomazine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.13e-05	0.000566	CbGpPWpGaD
Propiomazine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.12e-05	0.000565	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.11e-05	0.000565	CbGpPWpGaD
Propiomazine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.09e-05	0.000563	CbGpPWpGaD
Propiomazine—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.07e-05	0.000561	CbGpPWpGaD
Propiomazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.04e-05	0.000559	CbGpPWpGaD
Propiomazine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.04e-05	0.000559	CbGpPWpGaD
Propiomazine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7e-05	0.000556	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.98e-05	0.000555	CbGpPWpGaD
Propiomazine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.92e-05	0.00055	CbGpPWpGaD
Propiomazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.91e-05	0.000549	CbGpPWpGaD
Propiomazine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.91e-05	0.000549	CbGpPWpGaD
Propiomazine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.89e-05	0.000547	CbGpPWpGaD
Propiomazine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.89e-05	0.000547	CbGpPWpGaD
Propiomazine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.86e-05	0.000545	CbGpPWpGaD
Propiomazine—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.86e-05	0.000545	CbGpPWpGaD
Propiomazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.83e-05	0.000542	CbGpPWpGaD
Propiomazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.8e-05	0.00054	CbGpPWpGaD
Propiomazine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.8e-05	0.00054	CbGpPWpGaD
Propiomazine—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	6.78e-05	0.000538	CbGpPWpGaD
Propiomazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.78e-05	0.000538	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.78e-05	0.000538	CbGpPWpGaD
Propiomazine—DRD4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.75e-05	0.000536	CbGpPWpGaD
Propiomazine—CHRM4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.66e-05	0.000529	CbGpPWpGaD
Propiomazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.54e-05	0.000519	CbGpPWpGaD
Propiomazine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.45e-05	0.000512	CbGpPWpGaD
Propiomazine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.43e-05	0.000511	CbGpPWpGaD
Propiomazine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.41e-05	0.000509	CbGpPWpGaD
Propiomazine—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.39e-05	0.000508	CbGpPWpGaD
Propiomazine—CHRM5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.38e-05	0.000507	CbGpPWpGaD
Propiomazine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.33e-05	0.000503	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.31e-05	0.000501	CbGpPWpGaD
Propiomazine—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.08e-05	0.000483	CbGpPWpGaD
Propiomazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.03e-05	0.000479	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.03e-05	0.000479	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6e-05	0.000476	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.94e-05	0.000472	CbGpPWpGaD
Propiomazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.92e-05	0.00047	CbGpPWpGaD
Propiomazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.9e-05	0.000469	CbGpPWpGaD
Propiomazine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.88e-05	0.000467	CbGpPWpGaD
Propiomazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.82e-05	0.000463	CbGpPWpGaD
Propiomazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.81e-05	0.000461	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.77e-05	0.000458	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.69e-05	0.000452	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.53e-05	0.000439	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.47e-05	0.000435	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.45e-05	0.000433	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.42e-05	0.000431	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.4e-05	0.000429	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.38e-05	0.000427	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.35e-05	0.000425	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.27e-05	0.000418	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.24e-05	0.000416	CbGpPWpGaD
Propiomazine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.2e-05	0.000413	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.2e-05	0.000413	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.17e-05	0.000411	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.15e-05	0.000409	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.02e-05	0.000399	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.98e-05	0.000395	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.95e-05	0.000393	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.93e-05	0.000391	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.91e-05	0.00039	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.88e-05	0.000388	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.86e-05	0.000386	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.84e-05	0.000384	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.78e-05	0.00038	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.72e-05	0.000375	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.67e-05	0.000371	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.64e-05	0.000369	CbGpPWpGaD
Propiomazine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.59e-05	0.000365	CbGpPWpGaD
Propiomazine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.51e-05	0.000358	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.5e-05	0.000358	CbGpPWpGaD
Propiomazine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.49e-05	0.000357	CbGpPWpGaD
Propiomazine—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.48e-05	0.000356	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.45e-05	0.000354	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.44e-05	0.000353	CbGpPWpGaD
Propiomazine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.43e-05	0.000352	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.42e-05	0.000351	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.4e-05	0.000349	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.31e-05	0.000342	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.21e-05	0.000335	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.2e-05	0.000333	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.1e-05	0.000325	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.09e-05	0.000325	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.03e-05	0.00032	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.03e-05	0.00032	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.02e-05	0.000319	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.02e-05	0.000319	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.01e-05	0.000318	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4e-05	0.000317	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.98e-05	0.000316	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.96e-05	0.000314	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.95e-05	0.000313	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.92e-05	0.000311	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.91e-05	0.000311	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.9e-05	0.00031	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.89e-05	0.000309	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.88e-05	0.000308	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.84e-05	0.000305	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.83e-05	0.000304	CbGpPWpGaD
Propiomazine—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.82e-05	0.000303	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.81e-05	0.000303	CbGpPWpGaD
Propiomazine—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.77e-05	0.000299	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.72e-05	0.000295	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.66e-05	0.000291	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.65e-05	0.00029	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.65e-05	0.00029	CbGpPWpGaD
Propiomazine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.64e-05	0.000289	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.64e-05	0.000289	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.64e-05	0.000289	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.63e-05	0.000288	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.62e-05	0.000288	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.61e-05	0.000287	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.61e-05	0.000287	CbGpPWpGaD
Propiomazine—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.61e-05	0.000286	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.59e-05	0.000285	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.58e-05	0.000285	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.58e-05	0.000284	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.57e-05	0.000283	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.55e-05	0.000282	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.54e-05	0.000282	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.53e-05	0.000281	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.52e-05	0.00028	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.49e-05	0.000277	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.48e-05	0.000276	CbGpPWpGaD
Propiomazine—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.47e-05	0.000275	CbGpPWpGaD
Propiomazine—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.44e-05	0.000273	CbGpPWpGaD
Propiomazine—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.42e-05	0.000272	CbGpPWpGaD
Propiomazine—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.39e-05	0.000269	CbGpPWpGaD
Propiomazine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.31e-05	0.000263	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.3e-05	0.000262	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.29e-05	0.000261	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.28e-05	0.000261	CbGpPWpGaD
Propiomazine—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.27e-05	0.00026	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.25e-05	0.000258	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.24e-05	0.000257	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.23e-05	0.000257	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.19e-05	0.000253	CbGpPWpGaD
Propiomazine—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.12e-05	0.000248	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.1e-05	0.000246	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.08e-05	0.000244	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.05e-05	0.000243	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.96e-05	0.000235	CbGpPWpGaD
Propiomazine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.94e-05	0.000233	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.92e-05	0.000232	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.91e-05	0.000231	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.88e-05	0.000229	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.87e-05	0.000228	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.82e-05	0.000224	CbGpPWpGaD
Propiomazine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.81e-05	0.000223	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.79e-05	0.000221	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.76e-05	0.000219	CbGpPWpGaD
Propiomazine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.67e-05	0.000212	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.63e-05	0.000209	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.6e-05	0.000206	CbGpPWpGaD
Propiomazine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.59e-05	0.000206	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.56e-05	0.000203	CbGpPWpGaD
Propiomazine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.55e-05	0.000202	CbGpPWpGaD
Propiomazine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.54e-05	0.000202	CbGpPWpGaD
Propiomazine—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.53e-05	0.000201	CbGpPWpGaD
Propiomazine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.51e-05	0.000199	CbGpPWpGaD
Propiomazine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.5e-05	0.000198	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.49e-05	0.000198	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.42e-05	0.000192	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.38e-05	0.000189	CbGpPWpGaD
Propiomazine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.36e-05	0.000187	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.31e-05	0.000184	CbGpPWpGaD
Propiomazine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.31e-05	0.000184	CbGpPWpGaD
Propiomazine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.31e-05	0.000183	CbGpPWpGaD
Propiomazine—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.3e-05	0.000183	CbGpPWpGaD
Propiomazine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.28e-05	0.000181	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.27e-05	0.00018	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.25e-05	0.000179	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.2e-05	0.000174	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.16e-05	0.000172	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.16e-05	0.000171	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.16e-05	0.000171	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.15e-05	0.000171	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.14e-05	0.00017	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.13e-05	0.000169	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.12e-05	0.000169	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.12e-05	0.000168	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.1e-05	0.000167	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.09e-05	0.000166	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.09e-05	0.000166	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.08e-05	0.000165	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.06e-05	0.000164	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.05e-05	0.000163	CbGpPWpGaD
Propiomazine—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.05e-05	0.000163	CbGpPWpGaD
Propiomazine—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.02e-05	0.00016	CbGpPWpGaD
Propiomazine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.95e-05	0.000155	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.95e-05	0.000155	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.94e-05	0.000154	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.94e-05	0.000154	CbGpPWpGaD
Propiomazine—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.93e-05	0.000154	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.92e-05	0.000152	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.91e-05	0.000152	CbGpPWpGaD
Propiomazine—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.84e-05	0.000146	CbGpPWpGaD
Propiomazine—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.82e-05	0.000144	CbGpPWpGaD
Propiomazine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.58e-05	0.000125	CbGpPWpGaD
Propiomazine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.51e-05	0.00012	CbGpPWpGaD
Propiomazine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.39e-05	0.000111	CbGpPWpGaD
Propiomazine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.37e-05	0.000109	CbGpPWpGaD
Propiomazine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.36e-05	0.000108	CbGpPWpGaD
Propiomazine—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.36e-05	0.000108	CbGpPWpGaD
Propiomazine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.34e-05	0.000107	CbGpPWpGaD
Propiomazine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.34e-05	0.000106	CbGpPWpGaD
